Skip to search formSkip to main contentSkip to account menu

CS 747

Known as: 747, CS, CS-747, CS747 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Simple and effective biocompatible materials that mimic the natural extracellular matrix (ECM) were developed for a variety of… 
Highly Cited
2005
Highly Cited
2005
Background—Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa… 
Review
2005
Review
2005
CS-747 (prasugrel, LY640315) is a member of the thienopyridine class of oral platelet aggregation inhibitors that includes… 
Highly Cited
2004
Highly Cited
2004
Activation-induced deaminase (AID) is required for both immunoglobulin class switch recombination and somatic hypermutation. AID… 
Highly Cited
2002
Highly Cited
2002
We generated transgenic tomato plants with altered expression of heat stress transcription factor HsfA1. Plants with 10-fold… 
Highly Cited
2000
Highly Cited
2000
CS‐747 is a novel antiplatelet agent that generates an active metabolite, R‐99224, in vivo. CS‐747 itself was totally inactive in… 
Highly Cited
1998
Highly Cited
1998
The neural chondroitin sulfate (CS) proteoglycan (PG) DSD-1-PG was originally identified with the monoclonal antibody (mAb) 473HD…